The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The Neurobiology of Childhood Spinal Muscular Atrophy
Open accessAbstract
Almost to the century after the initial clinical description of childhood spinal muscular atrophy (SMA) (Werdnig, 1891) a new era of investigation into the nature of SMAwas inaugurated when Conrad Gilliam and his group at Columbia University established genetic linkage for this autosomal recessive disorder to chromosome 5q (Brzustowicz et al., 1990). In 6 years the pace of research has accelerated markedly: an extensive international effort to identify the gene is documented in over 50 papers by 240 authors at a dozen centers. One early by-product of this search was the discovery that the SMA-critical region of chromosome 5q is unusually unstable and that this genetic instability is likely responsible for the high incidence and worldwide distribution of SMA (Carpten et al., 1994; Theodosiou et al., 1994; Thompson et al., 1995; Crawford, 1996). By early 1995, the search had narrowed sufficiently for two neighboring but unrelated candidate genes to be proposed for the disorder (Lefebvre et al., 1995; Roy et al., 1995a). The arguments buttressing the candidacy of each of these two genes contrast strong biologic plausibility against high genetic probability. The plausible candidate gene, neuronal apoptosis inhibitory protein (NAIP), has displayed anti-apoptotic function—an activity that matches closely a standing hypothesis that SMA is a disorder of development. The probable candidate gene, survival motor neuron (SMN), is deleted in over 95% of patients with SMA and disabling point mutations have been found in a number of the remaining patients where they were pursued. Investigations into the pathogenesis of SMAare now turning to the cellular biology of NAIP and SMN and to the generation of gene-targeted animal models. Meanwhile, available animal models of motor neuron degeneration raise new questions about the multiple pathways of selective motor neuron vulnerability. New clinical insights and findings also raise some unexpected questions. The current vigor of SMA research stands as an outstanding illustration of how insight frommultiple levels—from epidemiology, clinical trials, and individual patient investigations to pathology, biochemistry, classic genetics, and now molecular genetics and cell biology—contribute to and draw strength from one another.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Cell death during development of the nervous system
Oppenheim, R. W. (1991) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.14.030191.002321 · Cited by 3,084
Population frequencies of inherited neuromuscular diseases—A world survey
Emery, A. E. H. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90039-u · Cited by 1,448
Rothe, M., Pan, M.-G., Henzel, W. J., Ayres, T. M., & V. Goeddel, D. (1995) · Cell · doi:10.1016/0092-8674(95)90149-3 · Cited by 1,253
Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
Listen, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton-Horvat, G., Farahani, R., McLean, M., lkeda, J.-E., Mackenzie, A., et al. (1996) · Nature · doi:10.1038/379349a0 · Cited by 1,014
Roy, N., Mahadevan, M. S., McLean, M., Shutter, G., Yaraghi, Z., Farahani, R., Baird, S., Besner-Johnston, A., Lefebvre, C., Kang, X., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90461-1 · Cited by 981
Self-citationPolyneuronal innervation of skeletal muscle in new‐born rats and its elimination during maturation.
Brown, M. C., Jansen, J. K., & Van Essen, D. (1976) · The Journal of Physiology · doi:10.1113/jphysiol.1976.sp011565 · Cited by 783
Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q1 1.2–13.3
Brzustowicz, L. M., Lehner, T., Castilla, L. H., Penchaszadeh, G. K., Wilhelmsen, K. C., Daniels, R., Davies, K. E., Leppert, M., Ziter, F., Wood, D., et al. (1990) · Nature · doi:10.1038/344540a0 · Cited by 613
Zerres, K. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540290108025 · Cited by 563
Cited by
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
RNA-binding proteins in human genetic disease
Gebauer, F., Schwarzl, T., Valcárcel, J., & Hentze, M. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00302-y · Cited by 1,176
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Burghes, A. H. M., & Beattie, C. E. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2670 · Cited by 723
Monani, U. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.333 · Cited by 729
Liu, Q., Fischer, U., Wang, F., & Dreyfuss, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80367-0 · Cited by 657
RNA-binding proteins in human genetic disease
Lukong, K. E., Chang, K.-W., Khandjian, E. W., & Richard, S. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.05.004 · Cited by 646
Kolb, S. J., & Kissel, J. T. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.004 · Cited by 603
Le, T. T., Pham, L. T., Butchbach, M. E. R., Zhang, H. L., Monani, U. R., Coovert, D. D., Gavrilina, T. O., Xing, L., Bassell, G. J., & Burghes, A. H. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi078 · Cited by 598
Passini, M. A., Bu, J., Richards, A. M., Kinnecom, C., Sardi, S. P., Stanek, L. M., Hua, Y., Rigo, F., Matson, J., Hung, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001777 · Cited by 547
Ratni, H., Ebeling, M., Baird, J., Bendels, S., Bylund, J., Chen, K. S., Denk, N., Feng, Z., Green, L., Guerard, M., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00741 · Cited by 537
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
Naryshkin, N. A., Weetall, M., Dakka, A., Narasimhan, J., Zhao, X., Feng, Z., Ling, K. K. Y., Karp, G. M., Qi, H., Woll, M. G., et al. (2014) · Science · doi:10.1126/science.1250127 · Cited by 524
Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function
Swoboda, K. J., Prior, T. W., Scott, C. B., McNaught, T. P., Wride, M. C., Reyna, S. P., & Bromberg, M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20473 · Cited by 478
Induced pluripotent stem cells — opportunities for disease modelling and drug discovery
Grskovic, M., Javaherian, A., Strulovici, B., & Daley, G. Q. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3577 · Cited by 474
Kariya, S., Park, G.-H., Maeno-Hikichi, Y., Leykekhman, O., Lutz, C., Arkovitz, M. S., Landmesser, L. T., & Monani, U. R. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn156 · Cited by 445
McWhorter, M. L., Monani, U. R., Burghes, A. H. M., & Beattie, C. E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303168 · Cited by 423
Kong, L., Wang, X., Choe, D. W., Polley, M., Burnett, B. G., Bosch-Marcé, M., Griffin, J. W., Rich, M. M., & Sumner, C. J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4434-08.2009 · Cited by 398
Gabanella, F., Butchbach, M. E. R., Saieva, L., Carissimi, C., Burghes, A. H. M., & Pellizzoni, L. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000921 · Cited by 315
Valproic acid increases SMN levels in spinal muscular atrophy patient cells
Sumner, C. J., Huynh, T. N., Markowitz, J. A., Perhac, J. S., Hill, B., Coovert, D. D., Schussler, K., Chen, X., Jarecki, J., Burghes, A. H. M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10743 · Cited by 289
Treating Disease at the RNA Level with Oligonucleotides
Levin, A. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1705346 · Cited by 287
Meyer, K., Ferraiuolo, L., Schmelzer, L., Braun, L., McGovern, V., Likhite, S., Michels, O., Govoni, A., Fitzgerald, J., Morales, P., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2014.210 · Cited by 286
Rigo, F., Chun, S. J., Norris, D. A., Hung, G., Lee, S., Matson, J., Fey, R. A., Gaus, H., Hua, Y., Grundy, J. S., et al. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.212407 · Cited by 283
“The disease manifests as a neuromuscular disorder with severe muscle weakness and atrophy of the voluntary muscles of the limbs and trunk, with eventual paralysis as a result of the degeneration of motor neurons in the anterior horn of the spinal cord (Crawford and Pardo, 1996).”
BackgroundWirth, B., Karakaya, M., Kye, M. J., & Mendoza-Ferreira, N. (2020) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-102319-103602 · Cited by 255
Building Robust Transcriptomes with Master Splicing Factors
Jangi, M., & Sharp, P. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.054 · Cited by 141
“Although SMN1 is ubiquitously expressed, pathology is confined mainly to motor neurons and muscle, indicative of a cell-type-specific sensitivity to an altered splicing regulatory network (Crawford and Pardo, 1996).”
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy
Oliveira-Giacomelli, Á., Naaldijk, Y., Sardá-Arroyo, L., Gonçalves, M. C. B., Corrêa-Velloso, J., Pillat, M. M., de Souza, H. D. N., & Ulrich, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00325 · Cited by 50
Ohuchi, K., Funato, M., Kato, Z., Seki, J., Kawase, C., Tamai, Y., Ono, Y., Nagahara, Y., Noda, Y., Kameyama, T., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0059 · Cited by 34
Metadata
- Authors
- Crawford, T. O., & Pardo, C. A.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 1996-04
- Volume
- 3
- Issue
- 2
- Pages
- 97-110
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2070086105
- Cited by
- 523
- References
- 36
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.